NASDAQ: RXRX · Biotechnology
Over the past week, Recursion Pharmaceuticals (RXRX) saw about 26 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 35% bullish across the tracked sources. Wall Street is more constructive, with 3 of 7 analysts rating RXRX a buy.
There is little buzz around RXRX this week and broad agreement on direction, which is why it reads as a Sell.
Wall Street’s 43% buy share sits next to a crowd that ranges from News at 25% to X at 41%. No other tracker puts the two side by side.
Across 7 analysts the consensus is a Hold: 3 buy calls against 0 sell, with an average 12-month price target of $7.22.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is improving and the 3 sources only partly agree, so the read is a Sell.
Analysts sit 8 points above the crowd average of 35%, the professionals are more constructive than retail. The split is inside the crowd: X reads 41% bullish while News sits at 25%, a 16-point spread that single-source trackers miss.
Over the 30-day window, Recursion Pharmaceuticals (RXRX) buzz held subdued around 29.3 while the price drifted up 11.3% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 15.4M shares. Updated Aug 29, 2026. Over the last 7 trading days, RXRX held roughly flat. Buzz activity in the recent week averaged 33.2 and was variable, swinging between 21.3 and 46.1. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 17 of the 20 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for RXRX and 2001+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live RXRX sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Aug 29, 2026.
| Adanos signal | Sell |
|---|---|
| Analyst consensus | Hold (3 / 4 / 0) |
| Crowd bullish (7d) | 35% |
| Avg price target | $7.22 |
| Most bullish source | X, 41% |
| Most bearish source | News, 25% |
| Sentiment spread | 16 pts |
| Mentions (7d) | 26 |
| Market cap | $1.84B |
| EPS · Beta | -$0.99 · 1.1 |
| Revenue (TTM) | $54.9M · 0% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Recursion Pharmaceuticals (RXRX) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 35% bullish across 3 active sources. Those sources contribute 26 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Recursion Pharmaceuticals (RXRX) is fairly quiet with 5 mentions over the last 7 days; the 30-day context spans 9 tracked subreddits. The 7-day tone is 40% bullish; 3-day activity momentum is rising, suggesting building attention.
The crowd reads bearish on Recursion Pharmaceuticals (RXRX), averaging 35% bullish across 3 tracked sources over the last 7 days. The two ends of the range are X at 41% bullish and News at 25%, a 16-point spread. On the professional side, 3 of 7 analysts rate RXRX a buy.
Of the 7 analysts covering Recursion Pharmaceuticals (RXRX), 3 rate it a buy, 4 a hold and 0 a sell, for a hold consensus. The average price target is $7.22. That puts the street ahead of the crowd, which averages 35% bullish.
Recursion Pharmaceuticals (RXRX)'s cross-source average is bearish at 35% bullish. All 3 tracked sources lean bearish. Reddit reads 40% bullish, X reads 41% bullish and news coverage is the most negative at 25% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
The cross-source average is bearish for Recursion Pharmaceuticals (RXRX) at 35% bullish. All 3 tracked sources lean bearish. The most bearish reading is news at 25% bullish. 3-day activity momentum is falling on X, while reddit and news activity is rising. The sell signal carries 93/100 conviction.
X is the dominant discussion channel with 17 mentions (65% of total volume). Reddit contributes 5 mentions and News contributes 4 mentions. The cross-source average is bearish at 35% bullish, while reddit and news show rising 3-day activity. All 3 tracked sources lean bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. RXRX's sell signal at 93/100 conviction reflects a bearish cross-source average at 35% bullish. All 3 tracked sources lean bearish. It is a research shortcut, not financial advice.
The RXRX sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Sell signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key